Key facts
- This page summarizes Therese Marie Abrams's Form 3 filing for Schrodinger, Inc. (SDGR).
- 0 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 19 Mar 2026, 20:04.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Includes 15,195 unvested restricted stock units ("RSUs"), comprised of 850 unvested RSUs that will vest on February 9, 2027, (ii) 2,549 unvested RSUs that will vest in equal installments on each of March 5, 2027 and 2028, (iii) 4,836 unvested RSUs that will vest in equal installments on each of March 4, 2027, 2028 and 2029 and (iv) 6,960 unvested RSUs that will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, in each case, subject to the Reporting Person's continued service with the company. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Footnote F2
The option was granted on January 30, 2019 and is fully vested.
Footnote F3
The option was granted on February 5, 2020 and is fully vested.
Footnote F4
The option was granted on February 27, 2021 and is fully vested.
Footnote F5
The option was granted on February 9, 2022 and is fully vested.
Footnote F6
The option was granted on February 9, 2023. The shares underlying the option vested with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.
Footnote F7
The option was granted on March 4, 2024. The shares underlying the option vested with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.
Footnote F8
The option was granted on March 3, 2025. The shares underlying the option vested with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.
Footnote F9
The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030.
SEC remarks
1. This Form 3 is being filed late due to an administrative delay in obtaining the reporting person's EDGAR codes. This late filing is not due to any error of the reporting person. 2. Exhibit 24.1 Power of Attorney